1. New Paradigm: Adaptive Approach

   • Hikmet Akkız

   Review Article 30 June 2017 Pages: 219 - 221

2. Molecular Pathogenesis of Liver Cancer

   • Mehmet Ozturk
   • Tugce Batur
   • Cigdem Ozen

   Review Article 17 July 2017 Pages: 222 - 224

3. Signaling Pathways as Potential Therapeutic Targets in Hepatocarcinogenesis

   • Yeliz Yılmaz
   • Ayşim Güneş
   • Neşe Atabey

   Review Article 18 August 2017 Pages: 225 - 237

   

4. Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology)

   • Aysegul Ozakyol

   Review Article 19 June 2017 Pages: 238 - 240

5. Cancer Stem Cells in Hepatocellular Carcinoma

   • Tamer Yagci
   • Metin Cetin
   • Pelin Balcik Ercin

   Review Article 23 June 2017 Pages: 241 - 245

   

6. Surveillance of the Patients with High Risk of Hepatocellular Cancer

   • Necati Örmeci

   Review Article 20 June 2017 Pages: 246 - 249

7. Is That Possible to Stop or Cease the NASH to Turn into HCC?

   • Ahmet Uygun

   Review Article 22 July 2017 Pages: 250 - 255

8. Angiogenesis, Invasion, and Metastasis Characteristics of Hepatocellular Carcinoma

   • Şirin Yüksel
   • Cemaliye Boylu Akyerli
   • M. Cengiz Yakıcıer

   Review Article 07 August 2017 Pages: 256 - 259

9. Barcelona Clinic Liver Cancer (BCLC) Staging: Does It Cover All Our Expectation

   • Abdullah Sonsuz

   Review Article 27 June 2017 Pages: 260 - 261

10. Validation of a Liver Index and Its Significance for HCC Aggressiveness

    • Brian I. Carr
    • Vito Guerra

    Original Research 20 June 2017 Pages: 262 - 266

    

11. Liver Transplantation for Hepatocellular Carcinoma: Kent Hospital Experience

    • Cahit Yılmaz

    Abstract Open access 04 August 2017 Pages: 267 - 267

12. Liver Transplantation for Hepatocellular Carcinoma at Inonu University

    • Cuneyt Kayaalp
    • Volkan Ince
    • Sezai Yilmaz

    Review Article 03 July 2017 Pages: 268 - 271

    

13. Liver Transplantation for Hepatocellular Carcinoma: “Experience of Memorial Sisli Hospital”

    • Koray Acarlı

    Review Article 24 June 2017 Pages: 272 - 273

14. Hepatocellular Cancer: Is Recurrence Inevitable?

    • Levent Doganay

    Review Article 24 June 2017 Pages: 274 - 275

15. HCC Locoregional Therapies: Yttrium-90 (Y-90) Selective Internal Radiation Therapy (SIRT)

    • İsa Burak Güney

    Review Article 21 June 2017 Pages: 276 - 280

    

16. Yttrium-90 (Y-90) Resin Microsphere Therapy for Patients with Unresectable Hepatocellular Carcinoma: a Single-Center Experience

    • Semra İnce
    • Bülent Karaman
    • Nuri Arslan

    Abstract 20 June 2017 Pages: 281 - 281

17. Radiological Response to the Locoregional Treatment in Hepatocellular Carcinoma: RECIST, mRECIST, and Others

    • Mecit Kantarci
    • Berhan Pirimoglu

    Review Article 17 June 2017 Pages: 282 - 285

18. The Importance of Parameters: MPV, MPV/Thrombocyte Ratio and Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer

    • Ali Oğul
    • Berksoy Şahin
    • Pınar Kum

    Abstract 10 July 2017 Pages: 286 - 287

19. Enlighting the Shadow for Advanced Hepatocellular Carcinoma: Immunotherapy with Immune Checkpoint Inhibitors

    • Berksoy Sahin

    Review Article 23 August 2017 Pages: 288 - 290